title: The application of magnetization transfer to MR angiography with reduced total power.
abstract: Magnetization transfer (MT) techniques have been shown to significantly reduce background soft-tissue signal in time-of-flight magnetic resonance angiography. To achieve sufficient suppression, radio frequency (RF) pulses with tip angles on the order of 1000 degrees are typically used, resulting in significant RF power deposition in the patient. Although these power deposition levels do not exceed the FDA guidelines, they are significantly higher than those used in typical imaging techniques. The use of these same magnetization transfer pulses in applications at field strengths higher than 1.5 T will require MT power levels which exceed FDA safety standards. This report demonstrates that the total power deposition required to achieve background tissue suppression can be significantly reduced by the application of the saturation pulses only during the phase-encoding steps corresponding to the central portion of "k space." This technique allows equivalent soft tissue suppression with approximately 10% of the energy deposition of conventional magnetization transfer techniques.
mesh_terms: D016477:Artifacts; D002343:Carotid Artery, Internal / Q000033:anatomy & histology; D002536:Cerebral Arteries / Q000033:anatomy & histology; D004735:Energy Transfer; D006257:Head / Q000098:blood supply; D006801:Humans; D007089:Image Enhancement / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D007866:Leg / Q000098:blood supply; D018810:Magnetic Resonance Angiography / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D008279:Magnetic Resonance Imaging / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D018482:Muscle, Skeletal / Q000098:blood supply; D011829:Radiation Dosage; D011846:Radio Waves; D012815:Signal Processing, Computer-Assisted; D014481:United States; D014486:United States Food and Drug Administration